Pay in 4 interest-free payments of $7.10 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
The relationship between GLP-1 receptor agonists and anemia: Focus on semaglutide
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist originally developed for type 2 diabetes management and subsequently approved by the FDA for chronic weight management
Health Canada issued a counterfeit GLP-1 alert in January 2026
2024;27(6):S3767
While pricing may vary depending on the dosage, quantity, and retailer, the price of an individual injectable pen ranges from about $320 to about $380
US$ 22.77
US$ 25.49
US$ 24.33
US$ 29.65
US$ 22.83
US$ 29.46
US$ 20.15
